Joseph Ruybal is the Associate Director of Operations who works with transformative pharmaceutical companies and research institutions to bring the future of medicine to patients today. Joseph believes that clinical research patients’ voices need to be heard, and their trial experience should be the central focus of trial design as they are the drivers for tomorrow’s treatment options. Joseph has spent his last 10 years within clinical research, spanning across a multitude of indications including oncology, pediatric gastroenterology, and pediatric asthma and allergy.

Joseph received several research grants from the NIH and from the University of Colorado to study the role of eosinophils in intestinal epithelial dysfunction. Joseph’s work has resulted in publications in the American Journal of Pathology, the Journal of Pediatric Gastroenterology and Nutrition, the Journal of Allergy and Clinical Immunology, GUT, An International Journal of Gastroenterology and Hepatology, and The New England Journal of Medicine.

Joseph holds a Masters of Science in Management from Wake Forest University School of Business and a Bachelor of Science in Biology from Wake Forest University.